Musula, Lydia

Musula, Lydia was paid $135K by Medicaid between Jan 2018 and Oct 2024, across 24 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 33% of everything it billed.

33Billing provider infoMUSULA, LYDIA
PROVIDENCE, RI 02903

33aNPI1396141610assigned 11/13/2014

33bProvider typePhysician Assistant

28Total paid$135K

24GClaims2,622

24DCodes billed24

24AFirst – last monthJan 2018 – Oct 2024

Compared with peers

Next to other Physician Assistant providers in Rhode Island

Rank by total paid#27 of 215

Median peer was paid$17K

This provider vs. median7.9×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	287	$14K
2019	222	$10K
2020	421	$17K
2021	440	$21K
2022	465	$27K
2023	360	$22K
2024incomplete	427	$25K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	33%	367	351	$44K
80061	Lipid panel	21%	457	447	$29K
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	18%	367	322	$25K
83036	Hemoglobin; glycosylated (A1C)	9.2%	258	256	$12K
80048	Basic metabolic panel (calcium, ionized)	4.7%	264	251	$6K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	3.9%	264	241	$5K
85045		1.8%	182	180	$2K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	1.3%	29	29	$2K
85027		1.2%	92	89	$2K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	1.2%	12	12	$2K
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	1.0%	16	14	$1K
99392	Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years)	<1%	12	12	$1K

12 more codes

U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	<1%	16	$774.35
85007		<1%	79	$678.22
C9803	Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	<1%	16	$590.49
90461		<1%	17	$567.98
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	58	$479.75
83030		<1%	18	$361.52
80053	Comprehensive metabolic panel	<1%	14	$285.52
90460	Immunization administration through 18 years of age via any route, first or only component	<1%	19	$158.35
1036F		<1%	27	$0.27
3078F		<1%	13	$0.13
90686		<1%	13	$0.13
3079F		<1%	12	$0.12

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.